Uniqure Announces FDA Breakthrough Therapy Designation Granted To Amt-130 For The Treatment Of Huntington’S Disease
Reuters
04-17
April 17 (Reuters) - Uniqure NV :: *UNIQURE ANNOUNCES FDA BREAKTHROUGH THERAPY DESIGNATION GRANTED TO AMT-130 FOR THE TREATMENT OF HUNTINGTON’S DISEASE *UNIQURE NV: ADDITIONAL REGULATORY UPDATE & GUIDANCE ON BIOLOGICS LICENSE APPLICATION SUBMISSION EXPECTED IN Q2 2025